glutamic acid has been researched along with quinelorane in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (50.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Morris, M; Selley, DE; Sim, LJ; Tsai, KP | 1 |
Donzanti, BA; Hite, JF; Yamamoto, BK | 1 |
Behr, J; Gloveli, T; Heinemann, U; Schmitz, D | 1 |
Austin, JD; Kim, JH; Perugini, M; Vezina, P | 1 |
4 other study(ies) available for glutamic acid and quinelorane
Article | Year |
---|---|
D2 inhibition of stimulated Fos immunoreactivity in cultured tyrosine hydroxylase-ir hypothalamic neurons.
Topics: Animals; Dopamine Agonists; Dopamine D2 Receptor Antagonists; Fenoldopam; Glutamic Acid; GTP-Binding Proteins; Hypothalamus; Neurons; Potassium Chloride; Proto-Oncogene Proteins c-fos; Quinolines; Rats; Tyrosine 3-Monooxygenase | 1994 |
Extracellular glutamate levels increase with age in the lateral striatum: potential involvement of presynaptic D-2 receptors.
Topics: Aging; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dialysis; Dopamine Agents; Electrochemistry; Extracellular Space; Glutamates; Glutamic Acid; In Vitro Techniques; Male; Quinolines; Rats; Rats, Inbred F344; Receptors, Dopamine D2; Sulpiride; Synapses | 1993 |
Dopamine depresses excitatory synaptic transmission onto rat subicular neurons via presynaptic D1-like dopamine receptors.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Benzazepines; Dopamine; Dopamine Agonists; Dopamine Antagonists; Entorhinal Cortex; Excitatory Amino Acid Agonists; Excitatory Postsynaptic Potentials; Female; Glutamic Acid; Hippocampus; In Vitro Techniques; Neurons; Patch-Clamp Techniques; Perforant Pathway; Presynaptic Terminals; Quinolines; Rats; Rats, Wistar; Receptors, Dopamine D1; Sulpiride; Synaptic Transmission | 2000 |
Previous exposure to amphetamine enhances the subsequent locomotor response to a D1 dopamine receptor agonist when glutamate reuptake is inhibited.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Amphetamine; Animals; Benzazepines; Central Nervous System Stimulants; Dicarboxylic Acids; Dopamine Agonists; Drug Administration Schedule; Drug Synergism; Excitatory Amino Acid Agents; Glutamic Acid; Male; Microinjections; Motor Activity; Neurotransmitter Uptake Inhibitors; Nucleus Accumbens; Pyrrolidines; Quinolines; Rats; Receptors, Dopamine D1; Receptors, Dopamine D2; Time | 2001 |